This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sun, B. Articles by Hornsby, P. J. Search for Related Content PubMed PubMed Citation Articles by Sun, B. Articles by Hornsby, P. J.

Immortal ALT⁺ Human Cells Do Not Require Telomerase Reverse Transcriptase for Malignant Transformation

¹ Department of Physiology and Sam and Ann Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center, San Antonio, Texas and ² Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Requests for reprints: Peter J. Hornsby, University of Texas Health Science Center, STCBM Building, 15355 Lambda Drive, San Antonio, TX 78245. Phone: 210-562-5080; Fax: 281-582-3538; E-mail: hornsby{at}uthscsa.edu.

Many human cancer cells lack telomerase activity but nevertheless maintain telomeres via a process termed "alternative lengthening of telomeres" (ALT). Despite being immortal and having a telomere maintenance mechanism, ALT⁺ human fibroblasts require telomerase reverse transcriptase (hTERT) for tumor formation in immunodeficient mice when tested by s.c. injection. Here we show that three ALT⁺ human SV40-immortalized fibroblast cell lines require only oncogenic Ras^V12G to be converted to a fully tumorigenic state. When cells were implanted beneath the kidney capsule of immunodeficient mice, they invaded the kidney and neighboring organs and metastasized to the lungs. Ras^V12G-expressing ALT⁺ cells remained completely telomerase negative. Introduction of hTERT conferred strong telomerase activity but did not appreciably change the malignant properties of the cells. However, when cells were tested by s.c. injection, Ras^V12G-transduced ALT⁺ cells did not form tumors, and in this site, hTERT was required for tumorigenicity. These data show that when the s.c. injection method is used as an assay for tumorigenicity, hTERT may be artifactually scored as an oncogene; the subrenal capsule assay shows that ALT, as a telomere maintenance mechanism, is equivalent to hTERT in neoplastic transformation of human cells by oncogenes.

This article has been cited by other articles:

				R. Villa, M. G. Daidone, R. Motta, L. Venturini, C. De Marco, A. Vannelli, S. Kusamura, D. Baratti, M. Deraco, A. Costa, et al. Multiple Mechanisms of Telomere Maintenance Exist and Differentially Affect Clinical Outcome in Diffuse Malignant Peritoneal Mesothelioma Clin. Cancer Res., July 1, 2008; 14(13): 4134 - 4140. [Abstract] [Full Text] [PDF]

				A. Costa, M. G. Daidone, L. Daprai, R. Villa, S. Cantu, S. Pilotti, L. Mariani, A. Gronchi, J. D. Henson, R. R. Reddel, et al. Telomere Maintenance Mechanisms in Liposarcomas: Association with Histologic Subtypes and Disease Progression. Cancer Res., September 1, 2006; 66(17): 8918 - 8924. [Abstract] [Full Text] [PDF]

				R. P. Hill Identifying Cancer Stem Cells in Solid Tumors: Case Not Proven Cancer Res., February 15, 2006; 66(4): 1891 - 1896. [Abstract] [Full Text] [PDF]